---
pmid: '23395606'
title: Identification of a novel 'aggregation-prone'/'amyloidogenic determinant' peptide
  in the sequence of the highly amyloidogenic human calcitonin.
authors:
- Iconomidou VA
- Leontis A
- Hoenger A
- Hamodrakas SJ
journal: FEBS Lett
year: '2013'
full_text_available: false
doi: 10.1016/j.febslet.2013.01.031
---

# Identification of a novel 'aggregation-prone'/'amyloidogenic determinant' peptide in the sequence of the highly amyloidogenic human calcitonin.
**Authors:** Iconomidou VA, Leontis A, Hoenger A, Hamodrakas SJ
**Journal:** FEBS Lett (2013)
**DOI:** [10.1016/j.febslet.2013.01.031](https://doi.org/10.1016/j.febslet.2013.01.031)

## Abstract

1. FEBS Lett. 2013 Mar 18;587(6):569-74. doi: 10.1016/j.febslet.2013.01.031. Epub
 2013 Feb 8.

Identification of a novel 'aggregation-prone'/'amyloidogenic determinant' 
peptide in the sequence of the highly amyloidogenic human calcitonin.

Iconomidou VA(1), Leontis A, Hoenger A, Hamodrakas SJ.

Author information:
(1)Department of Cell Biology and Biophysics, Faculty of Biology, University of 
Athens, Panepistimiopolis, Athens 157 01, Greece. veconom@biol.uoa.gr

Calcitonin is a 32-residue polypeptide hormone, which takes part in calcium 
metabolism in bones. It may form amyloid fibrils. Amyloid fibrils are related 
with serious diseases known as amyloidoses. The amyloid form of calcitonin takes 
part in medullary thyroid carcinoma. A novel hexapeptide ((6)TCMLGT(11)) of 
human calcitonin was predicted as a possible 'aggregation-prone' peptide, which 
may play a role in amyloid formation. We investigated experimentally the ability 
of an analog of this hexapeptide (cysteine replaced by alanine, TAMLGT) to form 
amyloid fibrils utilizing TEM, X-ray fiber diffraction, ATR FT-IR spectroscopy, 
and polarized light microscopy. This peptide self-assembles into amyloid-like 
fibrils and fibrillogenesis is mediated via nuclei of liquid crystalline nature, 
known as spherulites.

Copyright Â© 2013 Federation of European Biochemical Societies. Published by 
Elsevier B.V. All rights reserved.

DOI: 10.1016/j.febslet.2013.01.031
PMID: 23395606 [Indexed for MEDLINE]
